Scientists have made an important discovery about one of the most dangerous forms of ovarian cancer, offering new hope for earlier detection and better treatment in the future.
This research, published in the journal Nature Communications, focuses on high-grade serous carcinoma, often called HGSC. This type of ovarian cancer is the most aggressive and is responsible for most ovarian cancer deaths.
Ovarian cancer is a serious disease that affects thousands of women each year. It is currently one of the leading causes of cancer-related deaths in women worldwide. One of the biggest challenges with ovarian cancer is that it is often diagnosed very late.
In the early stages, the disease usually does not cause clear symptoms, and there are no reliable screening tests that can detect it early. As a result, many women are diagnosed only after the cancer has already spread, making it much harder to treat successfully.
For many years, scientists believed that this type of ovarian cancer might not actually begin in the ovaries themselves. Instead, they suspected it might start in the fallopian tubes, which are the narrow tubes that connect the ovaries to the uterus. However, until now, the exact starting point of the cancer was not clearly understood.
In this new study, a research team led by Dr. Alexander Nikitin at Cornell University carefully investigated how this cancer begins. They discovered that a specific group of cells in the fallopian tubes is likely the origin of this deadly disease. These cells are known as pre-ciliated tubal epithelial cells.
They are not fully mature cells, but they are also not stem cells. Instead, they are in an early stage of development. Under normal conditions, these cells grow into ciliated cells, which have tiny hair-like structures that help move eggs and fluids through the fallopian tubes.
To better understand how cancer develops, the researchers carried out experiments using mice. They focused on two important genes called TP53 and RB1. These genes normally help protect the body from cancer by controlling how cells grow and divide. In many human cases of high-grade serous carcinoma, these genes are damaged or turned off.
The scientists turned off these protective genes in different types of cells. When they turned off the genes in stem cells, the cells did not become cancerous. Instead, they simply died. However, when the same genes were turned off in the pre-ciliated cells, something very different happened.
These cells began to grow uncontrollably and developed into cancer. This finding clearly shows that these pre-ciliated cells are the likely starting point of this aggressive disease.
The researchers also discovered that another gene, called Krt5, is very active in these pre-ciliated cells. When they focused on cells with high levels of Krt5 and turned off TP53 and RB1, the mice quickly developed aggressive ovarian cancer. This result strengthens the idea that these specific cells play a key role in how the cancer begins and grows.
This discovery is important because scientists already have a good understanding of how these pre-ciliated cells normally develop. This means researchers may now be able to identify the early changes that lead to cancer and possibly stop the disease before it becomes serious.
It also opens the door to new ways of detecting ovarian cancer earlier. For example, doctors may one day be able to look for changes in these specific cells or monitor genes like Krt5 to identify people at higher risk.
Although this study was carried out in mice, the structure and function of fallopian tubes in mice are very similar to those in humans. This suggests that the findings are likely relevant to people as well. However, more research using human tissues will be needed to confirm these results and to develop new tests or treatments based on this discovery.
Dr. Nikitin and his team believe that their work could eventually lead to more personalized care for women who are at high risk of ovarian cancer.
By understanding exactly where and how the cancer begins, doctors may be able to design better treatments that target the disease at its earliest stage. This could not only save lives but also improve the quality of life for many patients.
This breakthrough represents a major step forward in cancer research. It provides a clearer picture of how one of the deadliest cancers develops and offers real hope that, in the future, ovarian cancer can be detected earlier and treated more effectively.
If you care about cancer, please read studies that artificial sweeteners are linked to higher cancer risk, and how drinking milk affects risks of heart disease and cancer.
For more health information, please see recent studies about the best time to take vitamins to prevent heart disease, and results showing vitamin D supplements strongly reduces cancer death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
